In scenarios where you may well require usage of a medically-important drug for a significant or life-threatening problem in which there is absolutely no sector approved drug readily available in copyright and for which substitute standard therapies have unsuccessful or are unsuitable, Wellbeing copyright's Particular Access Programme (SAP) is out